BibTex RIS Cite

Famotidine-induced acquired long QT syndrome: a case report

Year 2012, Volume: 18 Issue: 1, 48 - 50, 01.02.2012

Abstract

Bir çok ilacın uzun QT sendromuna yol açtığı bilinmektedir. Famotidinin sık kullanımına rağmen bu ilacın neden olduğu uzun QT sendromu nadiren bildirilmiştir. Biz famotidinle ilişkili kazanılmış uzun QT sendromlu bir olgu sunduk.

References

  • 1. Cahoon WD Jr. Acquired QT prolongation. Prog Cardiovasc Nurs 2009;24(1):30-3
  • 2. Hulisz DT, Welko JR, Heiselman DE. Sinus arrest associated with continuous-infusion cimetidine. Pharmacotherapy 1993;13(1):64-7
  • 3. Endo T, Katoh T, Kiuchi K, Katsuta Y, Shimizu S, Takano T
  • Famotidine and acquired long QT syndrome. Am J Med 2000;108(5):438–9
  • 4. Lee KW, Kayser SR, Hongo RH, Tseng ZH, Scheinman MM
  • Famotidine and long QT syndrome. Am J Cardiol 2004;93(10):1325-7
  • 5. Gunasekaran TS, DuBrow I. Cisapride-induced long QT interval: what is the role of ranitidine? J Pediatr 1997;130(4):679-80
  • 6. Yang J, Russell DA, Bourdeau JE. Case report: ranitidineinduced bradycardia in a patient with dextrocardia. Am J Med Sci 1996;312(3):133-5
  • 7. Sugiyama A, Satoh Y, Takahara A, Nakamura Y, Shimizu- Sasamata M, Sato S, et al. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems. Eur J Pharmacol 2003;466(1-2):137-46
  • 8. Kenigsberg DN, Khanal S, Kowalski M, Krishnan SC
  • Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol 2007;49(12):1299-305
  • 9. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45

Famotidinin uyardığı uzun QT sendromu: olgu sunumu

Year 2012, Volume: 18 Issue: 1, 48 - 50, 01.02.2012

Abstract

It is known that a number of drugs caused acquired long QT syndrome. Although the often use of famotidine, acquired long QT syndrome associated with this drug has rarely been reported. We presented a case of famotidine associated with acquired long QT syndrome.

References

  • 1. Cahoon WD Jr. Acquired QT prolongation. Prog Cardiovasc Nurs 2009;24(1):30-3
  • 2. Hulisz DT, Welko JR, Heiselman DE. Sinus arrest associated with continuous-infusion cimetidine. Pharmacotherapy 1993;13(1):64-7
  • 3. Endo T, Katoh T, Kiuchi K, Katsuta Y, Shimizu S, Takano T
  • Famotidine and acquired long QT syndrome. Am J Med 2000;108(5):438–9
  • 4. Lee KW, Kayser SR, Hongo RH, Tseng ZH, Scheinman MM
  • Famotidine and long QT syndrome. Am J Cardiol 2004;93(10):1325-7
  • 5. Gunasekaran TS, DuBrow I. Cisapride-induced long QT interval: what is the role of ranitidine? J Pediatr 1997;130(4):679-80
  • 6. Yang J, Russell DA, Bourdeau JE. Case report: ranitidineinduced bradycardia in a patient with dextrocardia. Am J Med Sci 1996;312(3):133-5
  • 7. Sugiyama A, Satoh Y, Takahara A, Nakamura Y, Shimizu- Sasamata M, Sato S, et al. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems. Eur J Pharmacol 2003;466(1-2):137-46
  • 8. Kenigsberg DN, Khanal S, Kowalski M, Krishnan SC
  • Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol 2007;49(12):1299-305
  • 9. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45
There are 12 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Ebru Tekbaş This is me

Zuhal Arutürk This is me

Habib Çil This is me

Yahya İslamoğlu This is me

Publication Date February 1, 2012
Published in Issue Year 2012 Volume: 18 Issue: 1

Cite

APA Tekbaş, E., Arutürk, Z., Çil, H., İslamoğlu, Y. (2012). Famotidine-induced acquired long QT syndrome: a case report. Gaziantep Medical Journal, 18(1), 48-50.
AMA Tekbaş E, Arutürk Z, Çil H, İslamoğlu Y. Famotidine-induced acquired long QT syndrome: a case report. Gaziantep Medical Journal. February 2012;18(1):48-50.
Chicago Tekbaş, Ebru, Zuhal Arutürk, Habib Çil, and Yahya İslamoğlu. “Famotidine-Induced Acquired Long QT Syndrome: A Case Report”. Gaziantep Medical Journal 18, no. 1 (February 2012): 48-50.
EndNote Tekbaş E, Arutürk Z, Çil H, İslamoğlu Y (February 1, 2012) Famotidine-induced acquired long QT syndrome: a case report. Gaziantep Medical Journal 18 1 48–50.
IEEE E. Tekbaş, Z. Arutürk, H. Çil, and Y. İslamoğlu, “Famotidine-induced acquired long QT syndrome: a case report”, Gaziantep Medical Journal, vol. 18, no. 1, pp. 48–50, 2012.
ISNAD Tekbaş, Ebru et al. “Famotidine-Induced Acquired Long QT Syndrome: A Case Report”. Gaziantep Medical Journal 18/1 (February 2012), 48-50.
JAMA Tekbaş E, Arutürk Z, Çil H, İslamoğlu Y. Famotidine-induced acquired long QT syndrome: a case report. Gaziantep Medical Journal. 2012;18:48–50.
MLA Tekbaş, Ebru et al. “Famotidine-Induced Acquired Long QT Syndrome: A Case Report”. Gaziantep Medical Journal, vol. 18, no. 1, 2012, pp. 48-50.
Vancouver Tekbaş E, Arutürk Z, Çil H, İslamoğlu Y. Famotidine-induced acquired long QT syndrome: a case report. Gaziantep Medical Journal. 2012;18(1):48-50.